( )
,
,
III. :
16. :
1) , , - , , .
2) , , / .
3) - , , .
4) , .
17. : .
18. :
1) .., ..., , - - , . .
2) .., ..., , , .
19. : 3 .
20. :
1) WHO Guidelines for the screening, care and treatment of persons with hepatitis C infection 2014. WHO publication. http://apps.who.int/iris/bitstream/10665/111747/1/9789241548755_eng.pdf?ua=1&ua=1
2) EASL Clinical Practice Guidelines. Management of hepatitis C virus infection. Journal of Hepatology 2011;55:245264
3) EASL Clinical Practice Guidelines: Management of hepatitis C virus infection. Journal of Hepatology 2014;60j:392420
4) EASL Recommendations on Treatment of Hepatitis C 2015. Journal of Hepatology 2015; http://www.easl.eu/medias/cpg/HEPC-2015/Full-report.pdf
5) AASLD Diagnosis, Management, and Treatment of Hepatitis C: An Update. Hepatology 2009;49(4):1335-1374
6) Treatment of Genotype 1 Chronic Hepatitis C Virus Infection: 2011 Practice Guideline by the American Association for the Study of Liver Diseases, Hepatology 2011;54 (4):14331444
|
|
7) AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C 2014. http://www.hcvguidelines.org/fullreport
8) AASLD-IDSA An update to the Recommendations for Testing, Managing, and Treating Hepatitis C 2014 http://www.hcvguidelines.org/full-report-view
9) An update on the management of chronic hepatitis C: Consensus guidelines from the Canadian Association for the Study of the Liver. Can J Gastroenterol 2012;26(6):359-375
10) Protease inhibitor-based triple therapy in chronic hepatitis C: guidelines by the French Association for the Study of the Liver. Liver International 2012;32(10);14771492
11) UK consensus guidelines for the use of the protease inhibitors boceprevir and telaprevir in genotype 1 chronic hepatitis C infected patients. Alimentary Pharmacology and Therapeutics 2012;35(6):647-62
12) Treatment of chronic hepatitis C genotype 1 with triple therapy comprising telaprevir or boceprevir. Swiss Association for the Study of the Liver. Swiss Medical Weekly 2012;142:w13516
13)
14) European AIDS Clinical Society (EACS) guidelines for the treatment of HIV, HIV and hepatitis C co-infection, and HIV with other co-morbidities 2013; version 7
15) : , -α 2, -α 2b, , , , .
1